Organization Overview
Alternative names
aldesleukin (Proleukin) (1 trial)
arsenic trioxide (trisenox) (1 trial)
bevacizumab (avastin) (3 trials)
bortezomib (velcade) (1 trial)
capecitabine (xeloda) (2 trials)
doxorubicin (Doxil) (2 trials)
erlotinib (tarceva) (4 trials)
etoposide (vepesid) (3 trials)
fluorouracil (efudex) (1 trial)
gabapentin (neurontin) (1 trial)
Adenocarcinoma (Phase 2)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Body Weight (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Cholangiocarcinoma (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Gallbladder Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Lung Diseases (Phase 1)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Melanoma (Phase 2)
Multiple Myeloma (Phase 1)
Nausea (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 1)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 3)
Recurrence (Phase 1)
Sarcoma (Phase 1)
Vomiting (Phase 2)